Scilex Holding SCLX
NASDAQ SCLX
$5.79 -0.01 (-0.17%)
As of: Aug 21, 2026 · 12:11 PM EDT

Scilex Holding (SCLX) EPS (Basic) (2020 - 2026)

Scilex Holding (SCLX) posted quarterly EPS (Basic) of -$6.28 for Q1 2026, down 21.95% year-over-year from -$8.04 in Q1 2025, and up 99.79% quarter-over-quarter from -$3000.9 in Q4 2025.

Scilex Holding (SCLX) EPS (Basic) (2020 - 2026) Analysis & Trends

Scilex Holding's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$6.28 for Q1 2026.

  • In Q1 2026, EPS (Basic) fell 21.95% year-over-year to -$6.28; the TTM figure through Mar 2026 stood at -$60.9 (down 314.0% YoY), while the FY2025 annual figure was -$36477.0, down 187605.92% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$6.28, up from -$3000.9 in the prior quarter.
  • The five-year high for EPS (Basic) was $57.12 in Q3 2022, with the low at -$22167.7 in Q3 2025.
  • The 5-year median for EPS (Basic) is -$18.55 (2022), against an average of -$2756.5.
  • The sharpest annual moves came in 2022 and 2025: EPS (Basic) jumped 10097.51% in 2022, then plunged 173941.23% in 2025.
  • Scilex Holding's EPS (Basic) stood at -$4663.4 in 2022, then soared by 99.88% to -$5.75 in 2023, then surged by 70.01% to -$1.72 in 2024, then slumped by 173941.23% to -$3000.9 in 2025, then soared by 99.79% to -$6.28 in 2026.
  • Business Quant data shows SCLX's EPS (Basic) at -$6.28 in Q1 2026, -$3000.9 in Q4 2025, and -$22167.7 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 653.31 Bn 632.55 Bn 17.26 Bn 2.30
2 AbbVie 470.15 Bn 463.58 Bn 12.70 Bn 2.04
3 Merck 377.27 Bn 370.13 Bn 12.21 Bn -0.54
4 Novartis Ag 302.88 Bn 295.19 Bn 11.24 Bn 1.71
5 Astrazeneca 257.92 Bn 253.02 Bn 12.86 Bn 1.62
6 Amgen 236.83 Bn 222.84 Bn 7.24 Bn 4.40
7 Gilead Sciences 183.08 Bn 179.90 Bn 6.22 Bn -8.44
8 Pfizer 160.37 Bn 148.67 Bn 10.94 Bn -0.04
9 Gsk 106.08 Bn 101.91 Bn 8.24 Bn 0.29
10 Scilex Holding 39.90 Mn -72.88 Mn 3.97 Mn -16.65

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.28
Dec 31, 2025 -3,000.91
Sep 30, 2025 -22,167.70
Jun 30, 2025 -7,422.25
Mar 31, 2025 -5.15
Dec 31, 2024 -1.72
Sep 30, 2024 -1,209.82
Jun 30, 2024 -11.62
Mar 31, 2024 -8,331.17
Dec 31, 2023 -5.75
Sep 30, 2023 -22.07
Jun 30, 2023 -6.54
Mar 31, 2023 -7.60
Dec 31, 2022 -4,663.36
Sep 30, 2022 57.12
Jun 30, 2022 -36.29
Mar 31, 2022 -18.55
Dec 31, 2021 -97.57
Sep 30, 2021 -0.57
Jun 30, 2021 -0.42